# Propanc Biopharma, Inc.: Form 10-Q/A for the period ended Dec 31, 2011

- Company: [Propanc Biopharma, Inc.](/companies/ppcb.md) (CIK 1517681)
- Form: 10-Q/A
- Filed: 2012-03-07
- Accepted by EDGAR: Mar 7, 2012, 17:28 ET
- Period: 2011-12-31
- Accession: 0001354488-12-001037
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1517681/000135448812001037/prop_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517681/000135448812001037/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2011-10-01 to 2011-12-31 | $0 | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2011-07-01 to 2011-12-31 | $5.3k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2011-10-01 to 2011-12-31 | −$2.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2011-07-01 to 2011-12-31 | −$6.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2011-10-01 to 2011-12-31 | $614 | us-gaap:InterestExpense |
| Interest expense | 6 months, 2011-07-01 to 2011-12-31 | $797 | us-gaap:InterestExpense |
| Income tax | 3 months, 2011-10-01 to 2011-12-31 | −$170.5k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2011-07-01 to 2011-12-31 | −$173.9k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2011-10-01 to 2011-12-31 | −$2.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2011-07-01 to 2011-12-31 | −$5.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2011-10-01 to 2011-12-31 | −$0.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2011-07-01 to 2011-12-31 | −$0.09 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2011-07-01 to 2011-12-31 | −$40.2k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2011-07-01 to 2011-12-31 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | at 2011-12-31 | $4.8m | us-gaap:AssetsCurrent |
| Total assets | at 2011-12-31 | $4.9m | us-gaap:Assets |
| Current liabilities | at 2011-12-31 | $354.3k | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-12-31 | $354.3k | us-gaap:Liabilities |
| Shareholders' equity | at 2011-12-31 | $4.5m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1517681/000135448812001037/prop_10q.htm

Filed Mar 7, 2012.
Source: SEC EDGAR, the filing index for accession 0001354488-12-001037. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.